Day One Biopharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $20,070 | $8,192 | $0 | $560 |
Gross Profit | 18,480 | 7,485 | -116 | 280 |
EBITDA | 29,636 | -114,494 | -66,767 | -59,504 |
EBIT | -114,902 | -66,883 | -59,607 | |
Net Income | 37,037 | -4,407 | -62,412 | -54,511 |
Net Change In Cash | 20,070 | 8,192 | 0 | 560 |
Free Cash Flow | -4,971 | -66,255 | -49,729 | -41,380 |
Cash | 422,765 | 239,616 | 270,391 | 230,784 |
Basic Shares | 96,937 | 87,121 | 86,679 | 79,773 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -383 | -531 | -199 | -155 |
EBITDA | -206,064 | -146,378 | -72,544 | -43,658 |
EBIT | -206,100 | -146,909 | -72,743 | -43,813 |
Net Income | -188,917 | -132,176 | -70,442 | -40,506 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -199,047 | 240,581 | ||
Free Cash Flow | -150,077 | -109,900 | -56,539 | -13,581 |
Cash | 230,784 | 85,262 | 284,309 | 43,728 |
Basic Shares | 79,773 | 65,466 | 61,952 | 61,928 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.38 |
2024-06-30 | -$0.05 |
2024-03-31 | -$0.72 |
2023-12-31 | -$0.64 |
